Abstract:Thrombogenicity poses a challenge to the clinical translation of engineered grafts. Previously, small-diameter vascular grafts (sdVG) composed of fibrin hydrogel microfiber tubes (FMT) with an external poly(ε-caprolactone) (PCL) sheath supported long-term patency in mice. Towards the development of an sdVG with off-the-shelf availability, the FMT's shelf stability, scale-up, and successful conjugation of an antithrombotic drug to the fibrin scaffold are reported here. FMTs maintain mechanical stability and high-water retention after storage for one year in a freezer, in a refrigerator, or at room temperature. Low molecular weight heparin-conjugated fibrin scaffolds enabled local and sustained delivery during two weeks of enzymatic degradation. Upscaled fabrication of sdVGs provides natural biodegradable grafts with size and mechanics suitable for human application. Implantation in a carotid artery interposition porcine model exhibited no rupture with thrombi prevented in all heparinized sdVGs (n = 4) over 4-5 weeks. Remodeling of the sdVGs is demonstrated with endothelial cells on the luminal surface and initial formation of the medial layer by 4-5 weeks. However, neointimal hyperplasia at 4-5 weeks led to the stenosis and occlusion of most of the sdVGs, which must be resolved for future long-term in vivo assessments. The off-the-shelf, biodegradable heparinized fibrin sdVG layer limits acute thrombogenicity while mediating extensive neotissue formation as the PCL sheath maintains structural integrity. STATEMENT OF SIGNIFICANCE: To achieve clinical and commercial utility of small-diameter vascular grafts as arterial conduits, these devices must have off-the-shelf availability for emergency arterial bypass applications and be scaled to a size suitable for human applications. A serious impediment to clinical translation is thrombogenicity. Treatments have focused on long-term systemic drug therapy, which increases the patient's risk of bleeding complications, or coating grafts and stents with anti-coagulants, which minimally improves patient outcomes even when combined with dual anti-platelet therapy. We systematically modified the biomaterial properties to develop anticoagulant embedded, biodegradable grafts that maintain off-the-shelf availability, provide mechanical stability, and prevent clot formation through local drug delivery.

Bioinspired, Anticoagulative, 19F MRI‐Visualizable Bilayer Hydrogel Tubes as High Patency Small‐Diameter Vascular Grafts

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Bilayer Vascular Grafts with On-Demand NO and H2S Release Capabilities.

Anticoagulant Hydrogel Tubes with Poly(ɛ‐Caprolactone) Sheaths for Small‐Diameter Vascular Grafts

Hydrogel Small-Diameter Vascular Graft Reinforced with a Braided Fiber Strut with Improved Mechanical Properties

A small-diameter vascular graft immobilized peptides for capturing endothelial colony-forming cells

Red blood cell membrane-functionalized Nanofibrous tubes for small-diameter vascular grafts

Dynamically Cross-Linked Double-Network Hydrogels with Matched Mechanical Properties and Ideal Biocompatibility for Artificial Blood Vessels

Robust And Antiswelling Hollow Hydrogel Tube With Antibacterial And Antithrombotic Ability For Emergency Vascular Replacement

Glycocalyx‐Like Hydrogel Coatings for Small Diameter Vascular Grafts

Preparation and characterization of a polyvinyl alcohol/polyacrylamide hydrogel vascular graft reinforced with a braided fiber stent

Hydrogen Sulfide Releasing and Carboxybetaine Modified Vascular Graft with Enhanced Anticoagulant, Anticalcification, and Pro-Endothelialization Properties

Off-the-shelf, heparinized small diameter vascular graft limits acute thrombogenicity in a porcine model

Biomimetic Niche of Vascular Intima with Biophysical Orientation and Biochemical Stimulation for Rapid Endothelialization and Long-Term Patency

Biomimetic tri-layered small-diameter vascular grafts with decellularized extracellular matrix promoting vascular regeneration and inhibiting thrombosis with the salidroside

Hydrogel-complexed Small-Diameter Vascular Graft Loaded with Tissue-Specific Vascular Extracellular Matrix Components Used for Tissue Engineering.

Rapid Formation of Ultrahigh Strength Vascular Graft: Prolonging Clotting Time Micro-Dimension Hollow Vessels with Interpenetrating Polymer Networks

A compliant and biomimetic three-layered vascular graft for small blood vessels

3D printed grafts with gradient structures for organized vascular regeneration

Engineered Vascular Graft Using Nanoscale Decellularized Arteries Modified with Controlled-Release Heparin and Vascular Endothelial Growth Factor

Plant Cellulose-Based Biomimetic Artificial Small-Diameter Vascular Materials Enabled by Gradient Dual-Network Entanglement